2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Russell Swerdlow: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| S-Equol in Alzheimer's Disease 2 Trial S-equol and Placebo, Placebo and S-equol - Alzheimer Disease | Phase 1 / Phase 2 | Completed | Russell Swerdlow | 40 | 2017-05-05 | 2024-07-25 |
| Trial of Oxaloacetate in Alzheimer's Disease (TOAD) Oxaloacetate (OAA) 1g, Oxaloacetate (OAA) 2g - Alzheimer's Disease (AD) | Phase 1 | Completed | Russell Swerdlow | 32 | 2015-10-01 | 2021-07-09 |
Equol (1) · Oxaloacetic Acid (1)
United States (2)